featured
2023 Top Story in Dermatology: Prevalence of Methylchloroisothiazolinone/Methylisothiazolinone Contact Allergy in the US
Written by
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- DeKoven JG, Warshaw EM, Reeder MJ, et al. North American Contact Dermatitis Group patch test results: 2019-2020. Dermatitis. 2023;34(2):90-104.
- Maouad M, Fleischer Jr AB, Sherertz EF, et al. Significance-prevalence index number: a reinterpretation and enhancement of data from the North American Contact Dermatitis Group. J Am Acad Dermatol. 1999;41(4):573-576.
- Castanedo-Tardana MP, Zug KA. Methylisothiazolinone. Dermatitis. 2013;24(1):2-6.
- Reeder MJ, Warshaw E, Aravamuthan S, et al. Trends in the prevalence of Methylchloroisothiazolinone/Methylisothiazolinone contact allergy in North America and Europe. JAMA Dermatol. 2023;159(3):267-274.